Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma
Autor: | M.C. Copin, Françoise Galateau-Sallé, Jessica Zucman-Rossi, J-C Nault, Ilir Hysi, Paul Hofman, Anne Tallet, Pascal Andujar, Didier Jean, A Renier, F. Le Pimpec-Barthes, M-C Jaurand, Aurélie Cazes |
---|---|
Přispěvatelé: | Génomique fonctionnelle des tumeurs solides (U674), Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), Labex Immuno-oncology, Université Paris Descartes - Paris 5 (UPD5)-PRES Sorbonne Paris Cité, Service de chirurgie cardiaque [CHRU Lille], Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Laboratoire d'Anatomie Pathologique [CHU Caen], Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Tumorothèque de Caen Basse-Normandie (TCBN), Unité de recherche interdisciplinaire pour la prévention et le traitement des cancers (ANTICIPE), CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Régional de Lutte contre le Cancer François Baclesse [Caen] (UNICANCER/CRLC), UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU)-UNICANCER, Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Institut de Pathologie [CHU Lille], Pôle de Biologie Pathologie Génétique [CHU Lille], Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Centre Hospitalier Universitaire de Nice (CHU Nice), CHI Créteil, Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Service de Chirurgie Thoracique, Paris, This work was supported by funds and grants from INSERM, the University of Paris-Descartes, the French League against Cancer (Ligue Nationale Contre le Cancer, 'Carte d’Identité des Tumeurs' CIT1 and CIT2 programs and the Comité de l’Oise), and the Chancellerie des Universités de Paris (Legs POIX)., Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Tumorothèque de Caen Basse-Normandie (TCBN)-Centre Régional de Lutte contre le Cancer François Baclesse [Caen] (UNICANCER/CRLC), Normandie Université (NU)-UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN)-UNICANCER-Institut National de la Santé et de la Recherche Médicale (INSERM), Jean, Didier |
Jazyk: | angličtina |
Rok vydání: | 2014 |
Předmět: |
telomerase reverse transcriptase (TERT)
Cancer Research Telomerase Lung Neoplasms Thoracic neoplasm [SDV.BBM.BM] Life Sciences [q-bio]/Biochemistry Molecular Biology/Molecular biology medicine.disease_cause Bioinformatics 0302 clinical medicine Gene expression CDKN2A Gene Inactivation Promoter Regions Genetic Regulation of gene expression 0303 health sciences telomere MESH: Telomerase MESH: Gene Expression Regulation Gene Expression Regulation Neoplastic 030220 oncology & carcinogenesis mesothelioma [SDV.BBM.GTP] Life Sciences [q-bio]/Biochemistry Molecular Biology/Genomics [q-bio.GN] MESH: Mutation MESH: Neoplastic Pleural Neoplasms [SDV.CAN]Life Sciences [q-bio]/Cancer [SDV.BC]Life Sciences [q-bio]/Cellular Biology [SDV.GEN.GH] Life Sciences [q-bio]/Genetics/Human genetics Biology MESH: Pleural Neoplasms 03 medical and health sciences [SDV.CAN] Life Sciences [q-bio]/Cancer [SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry Molecular Biology/Genomics [q-bio.GN] MESH: Promoter Regions Genetic Genetics medicine Humans Telomerase reverse transcriptase RNA Messenger [SDV.BC] Life Sciences [q-bio]/Cellular Biology Molecular Biology 030304 developmental biology MESH: RNA Messenger MESH: Humans MESH: Mesothelioma Mesothelioma Malignant [SDV.BBM.BM]Life Sciences [q-bio]/Biochemistry Molecular Biology/Molecular biology asbestos Telomere MESH: Lung Neoplasms [SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human genetics Cancer cell Cancer research mutation Carcinogenesis |
Zdroj: | Oncogene Oncogene, Nature Publishing Group, 2014, 33 (28), pp.3748-3752. ⟨10.1038/onc.2013.351⟩ Oncogene, 2014, 33 (28), pp.3748-3752. ⟨10.1038/onc.2013.351⟩ |
ISSN: | 0950-9232 1476-5594 |
DOI: | 10.1038/onc.2013.351⟩ |
Popis: | International audience; Malignant pleural mesothelioma (MPM) is a very aggressive tumor with no known curative treatment. Better knowledge of the molecular mechanisms of mesothelial carcinogenesis is required to develop new therapeutic strategies. MPM, like all cancer cells, needs to maintain telomere length to prevent senescence. Previous studies suggested that the telomere lengthening mechanism in MPM is based mainly on telomerase activity. For this reason, we focused on the key catalytic enzyme, TERT (telomerase reverse transcriptase), by analyzing its gene expression in MPM and by studying the mechanism underlying its upregulation. We used our large collection of MPM composed of 61 MPM in culture and 71 frozen MPM tumor samples. Evaluation of TERT mRNA expression by quantitative RT-PCR showed overexpression in MPM in culture compared with normal mesothelial cells, and in MPM tumor samples compared with normal pleura. We identified a 'hot spot' of mutations in the TERT gene core promoter in both MPM in culture and in MPM tumor samples with an overall frequency of 15%. Furthermore, data clearly identified mutation in the TERT promoter as a mechanism of TERT mRNA upregulation in MPM. In contrast, gene copy number amplification was not associated with TERT overexpression. Then, we analyzed the clinicopathological, etiological and genetic characteristics of MPM with mutations in the TERT promoter. TERT promoter mutations were more frequent in MPM with sarcomatoid histologic subtype (P |
Databáze: | OpenAIRE |
Externí odkaz: |